Page 86 - OR-1-1

Dis. 2023;9(1):22. A modulator of wild-type glucocerebrosidase improves
pathogenic phenotypes in dopaminergic neuronal models of
doi: 10.1038/s41531-023-00456-6
Parkinson’s disease. Sci Transl Med. 2019;11(514):eaau6870.
133. Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet.
2021;397(10291):2284-2303. doi: 10.1126/scitranslmed.aau6870
144. Zheng J, Jeon S, Jiang W, et al. Conversion of
doi: 10.1016/S0140-6736(21)00218-X
quinazoline modulators from inhibitors to activators of
134. Takahashi K, Yamanaka S. Induction of pluripotent stem β-glucocerebrosidase. J Med Chem. 2019;62(3):1218-1230.
cells from mouse embryonic and adult fibroblast cultures by
defined factors. Cell. 2006;126(4):663-676. doi: 10.1021/acs.jmedchem.8b01294
doi: 10.1016/j.cell.2006.07.024 145. Smits LM, Reinhardt L, Reinhardt P, et al. Modeling
Parkinson’s disease in midbrain-like organoids. NPJ
135. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent Parkinsons Dis. 2019;5:5.
stem cell lines derived from human somatic cells. Science.
2007;318(5858):1917-1920. doi: 10.1038/s41531-019-0078-4
doi: 10.1126/science.1151526 146. Babu HWS, Kumar SM, Kaur H, Iyer M, Vellingiri B.
Midbrain organoids for Parkinson’s disease (PD) - A
136. Garcia-Leon JA, Vitorica J, Gutierrez A. Use of human powerful tool to understand the disease pathogenesis. Life
pluripotent stem cell-derived cells for neurodegenerative Sci. 2024;345:122610.
disease modeling and drug screening platform. Future Med
Chem. 2019;11(11):1305-1322. doi: 10.1016/j.lfs.2024.122610
doi: 10.4155/fmc-2018-0520 147. Arenas E. Wnt signaling in midbrain dopaminergic neuron
development and regenerative medicine for Parkinson’s
137. Mazzulli JR, Zunke F, Isacson O, Studer L, Krainc D. disease. J Mol Cell Biol. 2014;6(1):42-53.
α-Synuclein-induced lysosomal dysfunction occurs
through disruptions in protein trafficking in human doi: 10.1093/jmcb/mju001
midbrain synucleinopathy models. Proc Natl Acad Sci U S A. 148. Kirkeby A, Grealish S, Wolf DA, et al. Generation of regionally
2016;113(7):1931-1936. specified neural progenitors and functional neurons from
doi: 10.1073/pnas.1520335113 human embryonic stem cells under defined conditions. Cell
Rep. 2012;1(6):703-714.
138. Mazzulli JR, Zunke F, Tsunemi T, et al. Activation of
β-glucocerebrosidase reduces pathological α-synuclein and doi: 10.1016/j.celrep.2012.04.009
restores lysosomal function in Parkinson’s patient midbrain 149. Shang J, Li B, Fan H, et al. Sevoflurane promotes premature
neurons. J Neurosci. 2016;36(29):7693-7706. differentiation of dopaminergic neurons in hiPSC-derived
doi: 10.1523/JNEUROSCI.0628-16.2016 midbrain organoids. Front Cell Dev Biol. 2022;10:941984.
139. Kim S, Yun SP, Lee S, et al. GBA1 deficiency negatively affects doi: 10.3389/fcell.2022.941984
physiological α-synuclein tetramers and related multimers. 150. Ma C, Seong H, Li X, Yu X, Xu S, Li Y. Human brain organoid:
Proc Natl Acad Sci U S A. 2018;115(4):798-803. A versatile tool for modeling neurodegeneration diseases
doi: 10.1073/pnas.1700465115 and for drug screening. Stem Cells Int. 2022;2022:2150680.
140. Lei T, Zhang X, Fu G, et al. Advances in human cellular doi: 10.1155/2022/2150680
mechanistic understanding and drug discovery of brain 151. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein
organoids for neurodegenerative diseases. Ageing Res Rev. locus triplication causes Parkinson’s disease. Science.
2024;102:102517. 2003;302(5646):841.
doi: 10.1016/j.arr.2024.102517 doi: 10.1126/science.1090278
141. Bolognin S, Fossépré M, Qing X, et al. 3D cultures of 152. Kim H, Park HJ, Choi H, et al. Modeling G2019S-LRRK2
Parkinson’s disease-specific dopaminergic neurons for high sporadic Parkinson’s disease in 3D midbrain organoids. Stem
content phenotyping and drug testing. Adv Sci (Weinh). Cell Reports. 2019;12(3):518-531.
2018;6(1):1800927.
doi: 10.1016/j.stemcr.2019.01.020
doi: 10.1002/advs.201800927
153. Wulansari N, Darsono WHW, Woo HJ, et al.
142. Pereira JD, DuBreuil DM, Devlin AC, et al. Human Neurodevelopmental defects and neurodegenerative
sensorimotor organoids derived from healthy and phenotypes in human brain organoids carrying
amyotrophic lateral sclerosis stem cells form neuromuscular Parkinson’s disease-linked DNAJC6 mutations. Sci Adv.
junctions. Nat Commun. 2021;12(1):4744.
2021;7(8):eabb1540.
doi: 10.1038/s41467-021-24776-4
doi: 10.1126/sciadv.abb1540. Erratum in: Sci Adv.
143. Burbulla LF, Jeon S, Zheng J, Song P, Silverman RB, Krainc D. 2023;9(44):eadl1498.

Volume 1 Issue 1 (2025) 20 doi: 10.36922/or.8261